eClinical Solutions Market increases in the number of Contract Research Organizations and life sciences organizations

eClinical solutions market is expected to reach USD 12.8 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base.

Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future.

The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF). 
The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the study suggest:

• In 2016, North America is estimated to lead the market with the largest share in the eClinical solutions industry. The rising number of ongoing clinical trials, high demand for technologically advanced products, and increasing financial support from the government is anticipated to boost the industry growth.
• The eCOA segment is anticipated to witness the highest growth rate during the forecast period, whereas the EDC and CDMS segment is estimated to lead the market in the year 2016. Factors attributing to the growth of the industry are the increasing application of mobile and digital technologies, as well as, an upsurge in the demand for eDiaries in clinical trials for the collection of patient’s self-reports by pharmaceutical companies.
• The eClinical solutions industry comprises several local as well as global players. Some of the major players in this industry include Oracle Corporation, Medidata Solutions Inc., Parexel International, Inc., and Datatrak, among others. 

Read detailed report or request for sample of this research report:

http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market/request

Digital Pathology Market is streamlining the diagnostic analysis development with amplified communication between healthcare professionals across the globe

The global market for digital cameras is expected to reach USD 19.77 billion by 2020, according to a new study by Grand View Research, Inc. Growing demand for interchangeable lens cameras with higher selling prices is expected to fuel industry growth over the forecast period. These include digital single lens reflex cameras (DSLR) as well as non-reflex cameras, also referred to as mirror less cameras. Increasing replacement demand coupled with technological enhancements such as Wi-Fi-enabled cameras is expected to favorably impact the market.

The trend of sharing images over the internet and availability of image processing tools has given impetus to the market. Widespread adoption of internet services and surge in social networking activities is expected to further bolster industry outlook. However, proliferation of smartphone globally is a major concern for industry participants, on account of the ready availability and convenience offered by smartphone cameras. The value chain consists of manufacturers of digital cameras and associated parts, as well as retailers or distributors.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market

 

Additionally, with the advent of Whole Slide Imaging (WSI), the market is anticipated to witness potential growth opportunities and is currently recognized as one of the foremost promising avenues in the field of diagnostic medicine. Reduced human error and improved accuracy attributable to the automated, slide scanning features, and algorithm-facilitated classification of disease conditions are some of the benefits associated with WSI that is presumed to further accelerate the demand in the future. Additionally, the high healthcare expenditure in the field of cancer diagnostics and the surging demand for personalized medicine has triggered the growth of the digital pathology field. The rising need for automation in image-based analytical tools employed for diagnosis is paving the way for the adoption of digital pathology systems.

High Implementation costs and a stringent regulatory framework pose as major hurdles in the incorporation of digital pathology solutions, particularly in the emerging economies. Currently, the digital pathology system is approved by the U.S. FDA for a limited number of applications, which are research-centric. The untapped diagnostic application areas in the U.S. serve as excellent opportunities for the industry players that are worth capitalizing in the near future. For example, in March 2016, Royal Philips entered into a collaborative agreement with Massachusetts General Hospital, wherein the latter is to serve as a testing center to conduct a multi center device precision study involving the former’s digital pathology WSI, IntelliSite Solution. The study is designed to determine the reproducibility of the IntelliSite pathology solution in primary diagnostic use pertinent to the field of cancer.

The digital pathology market is marked by dynamic activities, such as strategic partnerships which are imperative in widening the consumer base. Recently, in June 2016, the Dutch conglomerate, Royal Philips acquired the Irish, PathXL, one of the largest pathology, image-based analysis firms. This acquisition was carried out in order to develop integrated tools targeting applications in computational pathology, workflow solutions, education, and image analytics. Additionally, this acquisition is aimed at underpinning the gradual transition of medical institutions present across the globe from the traditional systems to digitized pathology systems. The aforementioned acquisition will further enable pathologists to perform high throughput analysis of colossal clinical data images sets that are diverse in nature and facilitate improvements in the diagnosis quality; thereby presenting a potential for the inclusion of new therapies and improvements to enhance patient health outcomes.

In 2014, another prominent market player, Objective Pathology formed a partnership with Microscopes International to introduce their new uSCOPEDigital Microscope to the Canadian market for geographical expansion. The future hence looks promising for the digital pathology industry with the sweeping digitization of tools employed in the diagnostics sector revolutionizing the healthcare industry across the globe.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market/request

Global Digital Camera Market is escalating replacement insist coupled with technological enhancements to positively collision the market

The global market for digital cameras is expected to reach USD 19.77 billion by 2020, according to a new study by Grand View Research, Inc. Growing demand for interchangeable lens cameras with higher selling prices is expected to fuel industry growth over the forecast period. These include digital single lens reflex cameras (DSLR) as well as non-reflex cameras, also referred to as mirror less cameras. Increasing replacement demand coupled with technological enhancements such as Wi-Fi-enabled cameras is expected to favorably impact the market.

The trend of sharing images over the internet and availability of image processing tools has given impetus to the market. Widespread adoption of internet services and surge in social networking activities is expected to further bolster industry outlook. However, proliferation of smartphone globally is a major concern for industry participants, on account of the ready availability and convenience offered by smartphone cameras. The value chain consists of manufacturers of digital cameras and associated parts, as well as retailers or distributors.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/digital-camera-industry

Further key findings from the study suggest:

• A global digital camera unit shipment was estimated to be 98.6 million units in 2012, and is expected to reach 171.7 million units by 2020
• Built-in lens cameras accounted for over 78% of the overall shipments in 2012. Interchangeable lens cameras contributed to over 50% of the market revenue in 2012, which can primarily be attributed to high selling prices of these products. Digital Single Lens Reflex (DSLR) cameras occupied over 80% of the market in 2012; however, they are expected to lose market share with an estimated CAGR of 3.8% from 2013 to 2020.
• Asia Pacific is expected to be the largest and fastest growing regional segment, and is estimated to grow at a CAGR of 8.1% over the forecast period to account for approximately 36% of the global market by 2020. This can primarily be attributed to rising purchasing power and relatively lower product penetration. Compact cameras with built-in lenses accounted for over 75% of regional shipments. Mirror less cameras are also compact in nature as compared to DSLRs, and have been witnessing growth in countries such as Japan and China.
• The market is dominated by Japanese participants; Canon Inc. and Nikon Corporation account for majority of the overall market share. Key players also include Sony Corporation, Samsung Electronics Corporation, Fujifilm Holdings, Olympus Corporation and Ricoh Imaging Company among others. Manufacturers have been focusing on the high-end product segment in order to stay competitive in an ecosystem characterized by changing user trends.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/digital-camera-industry/request

Dietary Supplements Market is increasing prevalence of premature births on a global level over the forecast period

The global dietary supplements market is expected to reach USD 278.02 billion by 2024, according to a new report by Grand View Research, Inc. Favorable outlook towards medical nutrition market in light of increasing application for the treatment of malnutrition and cardiovascular disorders is likely to promote the market for dietary supplements.

Rising sales of sports nutrition products in the U.S. and China on account of increasing prevalence of fitness and sports at a domestic level along with new product launches is likely to have a significant impact on the industry over the projected period. The market is expected to generate revenues worth USD 37.16 billion by 2024.

Rising consumption of clinical nutrition products as a prevention medium for reducing malnutrition is expected to have a substantial impact. Furthermore, increasing prevalence of premature births on a global level is expected to promote the use of medicinal supplements over the forecast period. The market was worth USD 19.17 billion in 2015 and is projected to witness growth at a CAGR of 9.5% from 2016 to 2024.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/dietary-supplements-market

Further key findings from the study suggest:

• The market for dietary supplement capsules was valued at USD 26.42 billion in 2015. The increasing use of omega-3 fatty acids in the formulation of dietary supplement capsules is expected to have a positive impact over the forecast period.
• Amino acid-based dietary supplements accounted for 14.3% of the market share in 2015 and are projected to witness significant growth on account of increasing protein intake by bodybuilders and sports athletes
• Gel caps and soft gels together accounted for 13.2% of the overall market in 2015. These products are expected to witness growth on account of their increasing application in confectionaries including chocolates, candies, and desserts.
• Asia Pacific is projected to growth at a CAGR of 11.2% from 2016 to 2024. Rising sales of green juice, royal jelly, blueberries, chlorella, and black vinegar in Japan owing to increasing awareness towards natural products is expected to promote the use of nutritional supplements over the forecast period.
• North America accounted for 28.5% of the total market in 2015 and is projected to witness growth on account of increasing consumption of products with reduced calorie level and high nutritional content
• Key participants include Amway Corporation, Pfizer Pharmaceuticals, Abbott Laboratories, Herbalife International, ADM, DuPont, and Carlyle Group. In April 2016, Amway Inc. launched a new sports nutrition energy drink under the brand name, XS Sports Nutrition line. This type of product innovation is expected to force manufacturers to develop new products over the next eight years.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/dietary-supplements-market/request